[ROS and NADPH oxidase: key regulators of tumor vascularisation]

Sarah Garrido-Urbani1, Vincent Jaquet1, Beat A Imhof1

  • 1Centre médical universitaire, département pathologie et immunologie, faculté de médecine, université de Genève, 1, rue Michel Servet, 1211 Genève, Suisse.

Medecine Sciences : M/S
|May 8, 2014
PubMed

Insights

Oxidative stress, caused by reactive oxygen species (ROS), damages cells but is vital for immune responses. NOX enzymes in endothelial cells are key players in tumor angiogenesis, promoting cancer growth and spread.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Oncology

Background:

  • Oxidative stress arises from an imbalance between reactive oxygen species (ROS) production and antioxidant defenses.
  • ROS are crucial for physiological processes, including immune defense and cell signaling.
  • Uncontrolled ROS contribute to cellular damage, affecting DNA, proteins, and lipids.

Purpose of the Study:

  • To explore the role of NOX enzymes in oxidative stress.
  • To investigate the specific function of NOX enzymes in endothelial cells.
  • To elucidate the involvement of NOX enzymes in tumor angiogenesis.

Main Methods:

  • Literature review on oxidative stress and NOX enzymes.
  • Analysis of NOX enzyme expression and activity in endothelial cells.
  • Examination of NOX-mediated ROS production in the context of tumor growth.

Main Results:

  • NOX enzymes are identified as significant contributors to ROS production.
  • Endothelial NOX enzymes play a critical role in regulating oxidative stress.
  • NOX enzymes are implicated in promoting tumor vasculature and metastasis.

Conclusions:

  • NOX enzymes are central to oxidative stress mechanisms.
  • Targeting endothelial NOX enzymes may offer therapeutic strategies for cancer.
  • Understanding NOX in angiogenesis is crucial for cancer research.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

3.8K